Aristotle University Of Thessaloniki (AUTH)
Μελέτη του εντερικού βλεννογόνου στις οροαρνητικές σπονδυλοαρθρίτιδες
Abstract
dc:descriptionRecent research has clearly shown that bowel mucosa participates in the aetiopathology of SPA. According to the theory of molecular mimicry, the presence of the HLA-B27 antigen in the cells of bowel mucosa contributes to the transport of antigens, microorganisms with the antigen presenting cells in the inner wall of bowel mucosa. Similar findings have been found in patients with idiopathic inflammatory bowel disease (IBD). This indicates a possible common pathogenesis of SPA and IBD. This study was carried out in 26 male patients with SPA and 18 normal controls. In both groups colonoscopy, biopsy of the bowel mucosa and permeability study of the bowel mucosa with Cr51-EDTA were performed. The immunohistochemistry study was performed using molecular indicators of cell proliferation (oncoantigen Ki67) and apoptosis (proteins p53, bax, bcl-2). Permeability studies were performed twice: Initially and after one month of continuous NSAID administration. HLA B27 antigen was detected in 26.9% of patients and in 6.3% of the controls. Colonoscopy showed macroscopic findings of inflammation in 8.3% of patients and in 5.6% in the control group. Microscopic findings from intestinal mucosa biopsies were detected in 82.6% of all patients and in 50% of the controls. NSAID administration did not affect bowel mucosa permeability. As far as we know, this is the first study that shows the absence of increased intestinal permeability in patients with SPA and normal controls. This permeability was evaluated using molecular markers of cell proliferation (oncoantigen Ki67) and proteins of apoptosis (p53, bax, bcl-2). The present study proves that the above mentioned balance between cell proliferation and apoptosis, perhaps has a protective role against possible oncogenesis to our patients.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Berberidis, Charalampos
- Μπερμπερίδης, Χαράλαμπος
Subjects
dc:subject × 19- Οροαρνητικές σπονδυλοαρθρίτιδες
- Διαπερατότητα εντερικού βλεννογόνου
- Μη στεροειδή αντιφλεγμονώδη φάρμακα
- Αγκυλωτική σπονδυλοαρθρίτιδα
- Φλεγμονώδη νοσήματα εντέρου
- Ογκογονίδιο Ki67
- Δείκτες αποπτώσεως P53, bax, bcl-2
- Seronegative spondyloarthropathies
- Gut permeability
- HLA B27
- Non steroidal anti-inflammatory drugs
- Ankylosing spondylitis
- Inflammatory bowel diseases (IBD)
- Oncoantigen Ki67
- Indicators of cell apoptosis P53, bax, bcl-2
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19439